Lehigh University College of Health Launches HEAL Service Center: A Cutting-Edge Shared High-Resolution Mass Spectrometry Facility

Why It Matters

The facility democratizes access to costly high‑resolution instrumentation, accelerating discovery and strengthening grant proposals for investigators. It also bolsters regional scientific infrastructure, supporting faster environmental monitoring and pharmaceutical development.

Key Takeaways

• Shared high‑resolution mass spectrometry facility launched
• Vanquish LC paired with Q Exactive Orbitrap
• Supports environmental toxicology, metabolomics, proteomics
• Provides expert staff for method development and data analysis
• Enhances grant competitiveness and regional research capacity

Pulse Analysis

Shared core facilities have become a strategic response to the soaring costs of high‑resolution mass spectrometry, allowing institutions to pool resources and expand analytical capacity without each lab shouldering the full capital expense. Lehigh University's HEAL Service Center exemplifies this model, offering a state‑of‑the‑art Vanquish LC‑Orbitrap platform that delivers sub‑ppm mass accuracy and ultra‑sensitive detection across diverse matrices. By centralizing expertise and equipment, the center not only reduces operational overhead but also accelerates project timelines for environmental health researchers seeking to identify trace contaminants or untangle complex metabolomic signatures.

Beyond the hardware, the HEAL Service Center’s value lies in its integrated scientific support. A PhD‑level research scientist guides investigators through every phase—from custom sample preparation to sophisticated data processing—ensuring reproducible results and robust statistical interpretation. This hands‑on assistance is especially critical for early‑career scientists and interdisciplinary teams that lack in‑house mass‑spec expertise. Moreover, the facility’s training programs equip students with practical skills in LC‑MS workflows, positioning them for competitive roles in academia, industry, and regulatory agencies while simultaneously enhancing the university’s grant competitiveness through high‑quality preliminary data.

Geographically, the center’s location within an hour of Philadelphia and New York creates a logistical advantage for regional stakeholders, from biotech firms needing rapid pharmacokinetic profiling to governmental labs monitoring emerging contaminants. The ability to deliver fast turnaround times and reliable analytical outputs strengthens collaborations, informs policy decisions, and supports compliance with tightening environmental regulations. As chemical mixtures grow more complex, platforms like HEAL will be essential for generating the high‑throughput, high‑resolution data that underpin next‑generation risk assessments and precision public‑health interventions.